Class 3 Medicines Recall: Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) Accord Healthcare Limited
Class 3 Medicines Recall: Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) Accord Healthcare Limited
July 23, 2020
Class 3 Medicines recall: Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) Accord Healthcare Limited
Drug alert number: EL (20) A/33
Date issued: 23 July 2020
The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for:
Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) Accord Healthcare Limited
Accord Healthcare Limited has informed MHRA they are recalling the above batch as a precautionary measure, due to the observation of precipitation in the solution in the same batch marketed in another country (Malta). No complaints or adverse reaction reports have been received by the company to date for the UK product.
Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) – PL 20075/0443
| Batch Number | Expiry Date | Pack Size | First Distributed |
| X21343 | 10/2021 | 1 x 5ml vial | 11/03/2019 |
Advice for healthcare professionals
- Stop supplying the batch listed above immediately.
- Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
For more information or medical information queries, please contact:
Medinfo-BST
Tel: 01271 385257
Email: medinfo@accord-healthcare.com
For stock control queries, please contact:
Accord-UK Ltd Customer Services Team
Tel: 0800 373573
Email: customerservices@accord-healthcare.com
Fax: 01271 346106
Posted in: Dispensing & Supply
